
Clinical workflows and natural language processing
NLP can help ensure clinical notes are standardized – but not all solutions are created equal.
Fresh perspectives on clinical terminologies, code mapping, and patient insights from the experts at IMO.
NLP can help ensure clinical notes are standardized – but not all solutions are created equal.
The proliferation of patient portals and personal health records has highlighted the importance of capturing and standardizing patient-generated data.
NLP can help ensure clinical notes are standardized – but not all solutions are created equal.
The proliferation of patient portals and personal health records has highlighted the importance of capturing and standardizing patient-generated data.
Tune into this webinar to learn from IMO’s VP of Enterprise IT and Security, Lori Kevin, and Associate General Counsel, Nicole Pearce, as they explain how you can fortify your security and be prepared to respond to current threats.
When it comes to value-based care, payment models can be tough to understand. We’re breaking down what you need to know below.
It’s no secret that artificial intelligence (AI) has been a buzzword in healthcare for several years. Learn why it’s also considered a wicked problem.
HCCs are important for reimbursement – but what differentiates a CMS HCC from an HHS one? Here are the basics.
IMO’s terminology-based approach to healthcare data standardization is helping Sharp HealthCare to unlock new value from patient information.
Learn how data normalization helps unify, clean, and organize highly variable clinical terminology into useful information.
Our latest white paper dives into electronic quality measurement and the challenges of moving from quality measurement to quality improvement.
A lot of interesting people work at IMO. Every month, we choose one to spotlight for In My Opinion. This month, IT’s Brian Gibson takes the mic.
In some surgical situations, the role of anesthesiology may seem incidental, but as Beth Kaylor, RN, explains, nothing could be further from the truth.
Pharmacogenomics, the study of how a person’s genes affect their response to medications, holds great potential – but obstacles to its adoption abound.
With the easing of COVID-19 restrictions countries are reducing genomic surveillance, limiting the data necessary to prepare for new variants.
Speakers will discuss how to simplify precise documentation for clinicians, the effects of imprecise coding on reimbursement, and more.